Quarterly report [Sections 13 or 15(d)]

SEGMENT INFORMATION (Tables)

v3.25.1
SEGMENT INFORMATION (Tables)
3 Months Ended
Mar. 31, 2025
SEGMENT INFORMATION  
Schedule of segment information

Three Months Ended March 31, 

2025

2024

(in thousands)

Total Revenues

$

53,333

$

29,534

Less:

Employee related expenses

19,538

19,367

Commercial related expenses

5,339

5,109

Outside clinical trial related expenses

4,371

2,512

Cost of product sales

4,409

2,025

Consultants and third-party services

3,409

4,343

Other segment items

3,494

3,144

Interest expense, net

1,262

1,281

Provision for income taxes

65

Segment income (loss)

$

11,446

$

(8,247)